ProCE Banner Activity

Expert Guidance on Screening and Diagnosing Early AD

Clinical Thought

A huge component of improving the outlook for patients with mild cognitive impairment or Alzheimer’s disease is early identification. Learn what tools are available to assist in detecting and confirming signs of dementia or cognitive dysfunction and understand the ever-evolving treatment landscape of Alzheimer’s disease.

Released: September 19, 2023



Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Eisai.



Primary Author

Susan Scanland, MSN, CRNP, GNP-BC, CDP: consultant/advisor/speaker: Acadia Pharmaceuticals, BioXcel, Eisai, Otsuka/Lundbeck, Teva Pharmaceuticals.